BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 32180495)

  • 1. Are pharmacists from the province of Quebec ready to integrate pharmacogenetics into their practice.
    Petit C; Croisetière A; Chen F; Laverdière I
    Pharmacogenomics; 2020 Mar; 21(4):247-256. PubMed ID: 32180495
    [No Abstract]   [Full Text] [Related]  

  • 2. Opinion, experience and educational preferences concerning pharmacogenomics: an exploratory study of Quebec pharmacists.
    Meloche M; Kwon HJ; Letarte N; Bussières JF; Vadnais B; Hurlimann T; Lavoie A; Beauchesne MF; de Denus S
    Pharmacogenomics; 2020 Mar; 21(4):235-245. PubMed ID: 32077363
    [No Abstract]   [Full Text] [Related]  

  • 3. An evaluation of pharmacists' expectations towards pharmacogenomics.
    de Denus S; Letarte N; Hurlimann T; Lambert JP; Lavoie A; Robb L; Sheehan NL; Turgeon J; Vadnais B
    Pharmacogenomics; 2013 Jan; 14(2):165-75. PubMed ID: 23327577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
    Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
    J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Community pharmacists' experience with pharmacogenetic testing.
    Moaddeb J; Mills R; Haga SB
    J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experience and expectations of pharmacogenetic tests in France.
    Verdez S; Bardou M; Duffourd Y; Luu M; Thauvin-Robinet C; Faivre L; Picard N
    Therapie; 2024; 79(3):341-349. PubMed ID: 37516659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of healthcare professionals' knowledge, attitudes, and perceived challenges of clinical pharmacogenetic testing in Egypt.
    Nagy M; Lynch M; Kamal S; Mohamed S; Hadad A; Abouelnaga S; Aquilante CL
    Per Med; 2020 Jul; 17(4):251-260. PubMed ID: 32589096
    [No Abstract]   [Full Text] [Related]  

  • 8. Knowledge, perceptions and confidence of physicians and pharmacists towards pharmacogenetics practice in Kuwait.
    Albassam A; Alshammari S; Ouda G; Koshy S; Awad A
    PLoS One; 2018; 13(9):e0203033. PubMed ID: 30183746
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists practising in family medicine groups: What are their activities and needs?
    Guénette L; Maheu A; Vanier MC; Dugré N; Rouleau L; Lalonde L
    J Clin Pharm Ther; 2020 Feb; 45(1):105-114. PubMed ID: 31436893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ready or not, here it comes: Direct-to-consumer pharmacogenomic testing and its implications for community pharmacists.
    Gammal RS; Mayes J; Caudle KE
    J Am Pharm Assoc (2003); 2019; 59(5):646-650. PubMed ID: 31327749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A nationwide cross-sectional survey of pharmacy students on pharmacogenetic testing in The Netherlands.
    Bank PC; Swen JJ; Guchelaar HJ
    Pharmacogenomics; 2018 Mar; 19(4):311-319. PubMed ID: 29473451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacogenetic testing in pediatric neurology: a pragmatic study evaluating clinician and patient perceptions.
    Pépin MA; Otis AS; Tremblay Z; Boulé M; Lebel D; Major P; Lortie A; Pinchefsky E; Rossignol E; Carleton B; Bussières JF; Métras MÉ
    Per Med; 2022 Sep; 19(5):423-434. PubMed ID: 35830229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacogenetics in clinical practice: current level of knowledge among Flemish physicians and pharmacists.
    Edris A; Vanoverschelde A; Bushaj P; Van Nieuwerburgh F; Lahousse L
    Pharmacogenomics J; 2021 Feb; 21(1):78-84. PubMed ID: 32848197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Knowledge, attitudes and education of pharmacists regarding pharmacogenetic testing.
    Roederer MW; Van Riper M; Valgus J; Knafl G; McLeod H
    Per Med; 2012 Jan; 9(1):19-27. PubMed ID: 29783293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of hospital pharmacists in the adoption and use of pharmacogenomics and precision medicine.
    Schwartz EJ; Issa AM
    Per Med; 2017 Jan; 14(1):27-35. PubMed ID: 29749827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prioritizing pharmacogenomics implementation initiates: a survey of healthcare professionals.
    Ho TT; Gift M; Alexander E
    Per Med; 2022 Jan; 19(1):15-23. PubMed ID: 34881640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of community pharmacists' knowledge and attitudes of pharmacogenomics testing: implication for improved pharmacogenomic testing practice.
    Ramadan A; Jarab AS; Al Meslamani AZ
    Hum Genomics; 2024 Jan; 18(1):8. PubMed ID: 38291455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing Increased Accessibility to Pharmacogenomic Data.
    Haga SB
    Clin Pharmacol Ther; 2019 Nov; 106(5):922-924. PubMed ID: 31482575
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmacogenetics: Knowledge assessment amongst Syrian pharmacists and physicians.
    Albitar L; Alchamat GA
    BMC Health Serv Res; 2021 Oct; 21(1):1031. PubMed ID: 34592972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacogenetic testing in primary care practice: opinions of physicians, pharmacists and patients.
    Frigon MP; Blackburn MÈ; Dubois-Bouchard C; Gagnon AL; Tardif S; Tremblay K
    Pharmacogenomics; 2019 Jun; 20(8):589-598. PubMed ID: 31190623
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.